Tudor Investment Corp’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$373K Buy
+2,967
New +$373K ﹤0.01% 1350
2024
Q1
Sell
-3,574
Closed -$471K 1787
2023
Q4
$471K Sell
3,574
-45,245
-93% -$5.96M ﹤0.01% 1152
2023
Q3
$5.49M Buy
+48,819
New +$5.49M 0.06% 342
2023
Q2
Sell
-5,016
Closed -$508K 1827
2023
Q1
$508K Sell
5,016
-43,036
-90% -$4.36M 0.01% 1134
2022
Q4
$5.74M Buy
+48,052
New +$5.74M 0.11% 193
2022
Q3
Sell
-42,694
Closed -$4.16M 1843
2022
Q2
$4.16M Buy
42,694
+39,675
+1,314% +$3.87M 0.11% 213
2022
Q1
$283K Sell
3,019
-41,521
-93% -$3.89M 0.01% 1297
2021
Q4
$3.79M Buy
44,540
+15,028
+51% +$1.28M 0.06% 343
2021
Q3
$2.83M Buy
29,512
+5,452
+23% +$523K 0.05% 432
2021
Q2
$2.34M Buy
+24,060
New +$2.34M 0.04% 472
2021
Q1
Sell
-26,854
Closed -$2.57M 1722
2020
Q4
$2.57M Sell
26,854
-11,898
-31% -$1.14M 0.07% 319
2020
Q3
$3.73M Buy
+38,752
New +$3.73M 0.16% 118
2020
Q1
Sell
-28,537
Closed -$3.07M 1225
2019
Q4
$3.07M Buy
28,537
+25,377
+803% +$2.73M 0.14% 167
2019
Q3
$285K Buy
+3,160
New +$285K 0.01% 860
2019
Q2
Sell
-10,419
Closed -$918K 1248
2019
Q1
$918K Sell
10,419
-10,739
-51% -$946K 0.04% 488
2018
Q4
$1.51M Sell
21,158
-2,000
-9% -$143K 0.03% 261
2018
Q3
$2.85M Buy
+23,158
New +$2.85M 0.07% 177
2018
Q2
Sell
-8,941
Closed -$741K 1149
2018
Q1
$741K Sell
8,941
-19,927
-69% -$1.65M 0.02% 419
2017
Q4
$2.24M Buy
+28,868
New +$2.24M 0.06% 141
2017
Q3
Sell
-5,428
Closed -$250K 1185
2017
Q2
$250K Buy
+5,428
New +$250K 0.01% 809
2015
Q2
Sell
-6,635
Closed -$263K 1569
2015
Q1
$263K Buy
+6,635
New +$263K 0.01% 1112
2013
Q4
Sell
-30,900
Closed -$350K 1314
2013
Q3
$350K Buy
+30,900
New +$350K 0.01% 504